AFMD (Affimed Therapeutics) שולי רווחיות גולמית

Affimed is developing innovative cancer immunotherapy while simultaneously implementing eco-friendly water filtration methods in its laboratories. The business's gross margin demonstrates the company's resilience to costs, with the current level standing at 0.00. The pristine condition of the equipment and strict adherence to drug batch release schedules confirm the high efficiency of the organization's production processes.
פילוחי מדדים פיננסיים ומדדי שוק עבור Affimed (AFMD)

This indicator determines production efficiency by measuring the share of profit from product sales minus all direct costs. Analyzing the gross margin after deducting the cost of goods sold allows for the identification of hidden accounting anomalies and an assessment of the business's real scaling potential. The ratio of the difference between revenue and cost of goods sold to total sales volume for Affimed (AFMD) is critical, as the costs of clinical trials for cell activators directly impact final profitability.